Challenges and opportunities of metabolomics
暂无分享,去创建一个
[1] E. Want,et al. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments , 2010, Proceedings of the National Academy of Sciences.
[2] J. Idle,et al. Metabolomic and genetic analysis of biomarkers for peroxisome proliferator-activated receptor alpha expression and activation. , 2007, Molecular endocrinology.
[3] John N Weinstein,et al. UPLC-ESI-TOFMS-based metabolomics and gene expression dynamics inspector self-organizing metabolomic maps as tools for understanding the cellular response to ionizing radiation. , 2008, Analytical chemistry.
[4] J. Idle,et al. Radiation Metabolomics. 3. Biomarker Discovery in the Urine of Gamma-Irradiated Rats Using a Simplified Metabolomics Protocol of Gas Chromatography-Mass Spectrometry Combined with Random Forests Machine Learning Algorithm , 2009, Radiation research.
[5] Caroline H. Johnson,et al. Radiation Metabolomics. 4. UPLC-ESI-QTOFMS-Based Metabolomics for Urinary Biomarker Discovery in Gamma-Irradiated Rats , 2011, Radiation research.
[6] J. Idle,et al. A Double Transgenic Mouse Model Expressing Human Pregnane X Receptor and Cytochrome P450 3A4 , 2008, Drug Metabolism and Disposition.
[7] R. Knight,et al. The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice , 2009, Science Translational Medicine.
[8] J. Idle,et al. A metabolomic approach to the metabolism of the areca nut alkaloids arecoline and arecaidine in the mouse. , 2006, Chemical research in toxicology.
[9] J. Lindon,et al. Pharmaco-metabonomic phenotyping and personalized drug treatment , 2006, Nature.
[10] Gary Siuzdak,et al. Nanostructure-initiator mass spectrometry metabolite analysis and imaging. , 2011, Analytical chemistry.
[11] Gary Siuzdak,et al. A nanostructure-initiator mass spectrometry-based enzyme activity assay , 2008, Proceedings of the National Academy of Sciences.
[12] W. R. Wikoff,et al. Metabolomics identifies perturbations in human disorders of propionate metabolism. , 2007, Clinical chemistry.
[13] Donald G Robertson,et al. Metabonomic identification of two distinct phenotypes in Sprague-Dawley (Crl:CD(SD)) rats. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[14] A. Fornace,et al. UPLC-MS-based urine metabolomics reveals indole-3-lactic acid and phenyllactic acid as conserved biomarkers for alcohol-induced liver disease in the Ppara-null mouse model. , 2011, Journal of proteome research.
[15] Matthias Heinemann,et al. Single cell metabolomics. , 2011, Current opinion in biotechnology.
[16] P. Britz‐McKibbin,et al. Metabolomic studies of radiation‐induced apoptosis of human leukocytes by capillary electrophoresis‐mass spectrometry and flow cytometry: Adaptive cellular responses to ionizing radiation , 2010, Electrophoresis.
[17] D. Wishart. Advances in metabolite identification. , 2011, Bioanalysis.
[18] D. Gauguier,et al. Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets. , 2005, Analytical chemistry.
[19] D. Guo,et al. Pregnane X receptor-mediated induction of Cyp3a by black cohosh , 2011, Xenobiotica; the fate of foreign compounds in biological systems.
[20] R. T. Williams,et al. The role of the gut flora in the metabolism of prontosil and neoprontosil in the rat. , 1971, Xenobiotica; the fate of foreign compounds in biological systems.
[21] Philip J. Marriott,et al. Principles and applications of comprehensive two-dimensional gas chromatography , 2002 .
[22] John C Lindon,et al. Pharmacometabonomics as an effector for personalized medicine. , 2011, Pharmacogenomics.
[23] D. Schaid,et al. Glycine and a Glycine Dehydrogenase (GLDC) SNP as Citalopram/Escitalopram Response Biomarkers in Depression: Pharmacometabolomics‐Informed Pharmacogenomics , 2011, Clinical pharmacology and therapeutics.
[24] David J Greenblatt,et al. The effect of grapefruit juice on drug disposition , 2011, Expert opinion on drug metabolism & toxicology.
[25] Albert J Fornace,et al. Radiation Metabolomics. 1. Identification of Minimally Invasive Urine Biomarkers for Gamma-Radiation Exposure in Mice , 2008, Radiation research.
[26] J. Idle,et al. Identification of Novel Toxicity-associated Metabolites by Metabolomics and Mass Isotopomer Analysis of Acetaminophen Metabolism in Wild-type and Cyp2e1-null Mice* , 2008, Journal of Biological Chemistry.
[27] O. Warburg. [Origin of cancer cells]. , 1956, Oncologia.
[28] Silas G. Villas-Boas,et al. Analytical methods from the perspective of method standardization , 2007 .
[29] Qian Yang,et al. Identification of noninvasive biomarkers for alcohol-induced liver disease using urinary metabolomics and the Ppara-null mouse. , 2010, Journal of proteome research.
[30] S. Z. Imam,et al. Medicinal importance of grapefruit juice and its interaction with various drugs , 2007, Nutrition journal.
[31] J. Nicholson,et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics , 2002, Nature Medicine.
[32] J. Nicholson,et al. Global systems biology and personalized healthcare solutions. , 2006, Discover medicine.
[33] J. Caldwell,et al. The role of intestinal microflora in the formation of the methylthio adduct metabolites of paracetamol. Studies in neomycin-pretreated and germ-free mice. , 1988, Biochemical pharmacology.
[34] A. Kassis,et al. Putative molecular signatures for the imaging of prostate cancer , 2010, Expert review of molecular diagnostics.
[35] Oscar Yanes,et al. Nanostructure initiator mass spectrometry: tissue imaging and direct biofluid analysis. , 2009, Analytical chemistry.
[36] Junefredo V. Apon,et al. Clathrate nanostructures for mass spectrometry , 2007, Nature.
[37] F. Wright,et al. Use of Pharmaco‐Metabonomics for Early Prediction of Acetaminophen‐Induced Hepatotoxicity in Humans , 2010, Clinical pharmacology and therapeutics.
[38] T. Fan,et al. Altered regulation of metabolic pathways in human lung cancer discerned by 13C stable isotope-resolved metabolomics (SIRM) , 2009, Molecular Cancer.
[39] Caroline H. Johnson,et al. Xenobiotic metabolomics: major impact on the metabolome. , 2012, Annual review of pharmacology and toxicology.
[40] J. Idle,et al. A metabolomic perspective of melatonin metabolism in the mouse. , 2008, Endocrinology.
[41] John C Lindon,et al. Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism , 2009, Proceedings of the National Academy of Sciences.
[42] Leo L. Cheng,et al. Metabolic characterization of human prostate cancer with tissue magnetic resonance spectroscopy. , 2005, Cancer research.
[43] Oliver Fiehn,et al. Plasma Metabolomic Profiles Reflective of Glucose Homeostasis in Non-Diabetic and Type 2 Diabetic Obese African-American Women , 2010, PloS one.
[44] Nigel W. Hardy,et al. Summary recommendations for standardization and reporting of metabolic analyses , 2005, Nature Biotechnology.
[45] E. Want,et al. HILIC-UPLC-MS for exploratory urinary metabolic profiling in toxicological studies. , 2011, Analytical chemistry.
[46] A. Darzi,et al. Metabolic phenotyping for monitoring surgical patients , 2011, The Lancet.
[47] Nigel W. Hardy,et al. A proposed framework for the description of plant metabolomics experiments and their results , 2004, Nature Biotechnology.
[48] J. Idle,et al. Rifampicin-Activated Human Pregnane X Receptor and CYP3A4 Induction Enhance Acetaminophen-Induced Toxicity , 2009, Drug Metabolism and Disposition.
[49] A. Fornace,et al. Radiation Metabolomics. 2. Dose- and Time-Dependent Urinary Excretion of Deaminated Purines and Pyrimidines after Sublethal Gamma-Radiation Exposure in Mice , 2009, Radiation research.
[50] M. Rantalainen,et al. Top-down systems biology modeling of host metabotype-microbiome associations in obese rodents. , 2009, Journal of proteome research.
[51] I. Wilson,et al. An NMR‐based metabonomic approach to investigate the biochemical consequences of genetic strain differences: application to the C57BL10J and Alpk:ApfCD mouse , 2000, FEBS letters.
[52] J. Ward,et al. THE CYP 2 E 1-HUMANIZED TRANSGENIC MOUSE : ROLE OF CYP 2 E 1 IN ACETAMINOPHEN HEPATOTOXICITY , 2004 .
[53] J. Idle,et al. The metabolomics of (+/-)-arecoline 1-oxide in the mouse and its formation by human flavin-containing monooxygenases. , 2007, Biochemical pharmacology.
[54] J. Idle,et al. A comprehensive investigation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) metabolism in the mouse using a multivariate data analysis approach. , 2007, Chemical research in toxicology.
[55] Y. Pommier,et al. Urinary Metabolite Profiling Reveals CYP1A2-Mediated Metabolism of NSC686288 (Aminoflavone) , 2006, Journal of Pharmacology and Experimental Therapeutics.
[56] I. Wilson,et al. The role of gut microbiota in drug response. , 2009, Current pharmaceutical design.
[57] R. L. Brown,et al. Development of a database of gas chromatographic retention properties of organic compounds. , 2007, Journal of chromatography. A.
[58] J C Lindon,et al. Biochemical classification of kidney carcinoma biopsy samples using magic-angle-spinning 1H nuclear magnetic resonance spectroscopy. , 1998, Journal of pharmaceutical and biomedical analysis.
[59] John C Lindon,et al. Kinetic and J-resolved statistical total correlation NMR spectroscopy approaches to structural information recovery in complex reacting mixtures: application to acyl glucuronide intramolecular transacylation reactions. , 2008, Analytical chemistry.
[60] Weiqun Li,et al. Metabolism of Fostamatinib, the Oral Methylene Phosphate Prodrug of the Spleen Tyrosine Kinase Inhibitor R406 in Humans: Contribution of Hepatic and Gut Bacterial Processes to the Overall Biotransformation , 2010, Drug Metabolism and Disposition.
[61] I. Wilson,et al. High resolution "ultra performance" liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies. , 2005, Journal of proteome research.
[62] J. Idle,et al. Fenofibrate Metabolism in the Cynomolgus Monkey using Ultraperformance Liquid Chromatography-Quadrupole Time-of-Flight Mass Spectrometry-Based Metabolomics , 2009, Drug Metabolism and Disposition.
[63] Julian L Griffin,et al. Proton NMR analysis of plasma is a weak predictor of coronary artery disease , 2006, Nature Medicine.
[64] Ian D Wilson,et al. Hydrophilic interaction and reversed-phase ultra-performance liquid chromatography TOF-MS for metabonomic analysis of Zucker rat urine. , 2008, Journal of separation science.
[65] Ai-Ming Yu,et al. THE CYP2E1-HUMANIZED TRANSGENIC MOUSE: ROLE OF CYP2E1 IN ACETAMINOPHEN HEPATOTOXICITY , 2005, Drug Metabolism and Disposition.
[66] Yves Gibon,et al. GMD@CSB.DB: the Golm Metabolome Database , 2005, Bioinform..
[67] John O. Prior,et al. Early prediction of response to sunitinib after imatinib failure by 18F-fluorodeoxyglucose positron emission tomography in patients with gastrointestinal stromal tumor. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[68] J. Idle,et al. Comparative metabolism of cyclophosphamide and ifosfamide in the mouse using UPLC-ESI-QTOFMS-based metabolomics. , 2010, Biochemical pharmacology.
[69] S. Bartz,et al. Attenuation of Slc27a5 gene expression followed by LC-MS measurement of bile acid reconjugation using metabolomics and a stable isotope tracer strategy. , 2011, Journal of proteome research.
[70] Elaine Holmes,et al. A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model , 2007, Molecular systems biology.
[71] Kazuki Saito,et al. Potential of metabolomics as a functional genomics tool. , 2004, Trends in plant science.
[72] Warwick B Dunn,et al. Current trends and future requirements for the mass spectrometric investigation of microbial, mammalian and plant metabolomes , 2008, Physical biology.
[73] D. Nebert,et al. Differential metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mice humanized for CYP1A1 and CYP1A2. , 2005, Chemical research in toxicology.
[74] A. Lane,et al. Metabolic profiling identifies lung tumor responsiveness to erlotinib. , 2009, Experimental and molecular pathology.
[75] P. Arn,et al. Newborn screening: current status. , 2007, Health affairs.
[76] O. Pelkonen,et al. CYP2A5/CYP2A6 expression in mouse and human hepatocytes treated with various in vivo inducers. , 2000, Drug metabolism and disposition: the biological fate of chemicals.
[77] O. Fiehn,et al. FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry. , 2009, Analytical chemistry.
[78] Matthew R. Redinbo,et al. Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme , 2010, Science.
[79] F. Gonzalez,et al. Metabolomics identifies novel Hnf1alpha-dependent physiological pathways in vivo. , 2010, Molecular endocrinology.
[80] T. Kodama,et al. Therapeutic Role of Rifaximin in Inflammatory Bowel Disease: Clinical Implication of Human Pregnane X Receptor Activation , 2010, Journal of Pharmacology and Experimental Therapeutics.
[81] Gabriel S. Eichler,et al. Metabolomics Reveals Attenuation of the SLC6A20 Kidney Transporter in Nonhuman Primate and Mouse Models of Type 2 Diabetes Mellitus* , 2011, The Journal of Biological Chemistry.
[82] P. Britz‐McKibbin,et al. Comprehensive plasma thiol redox status determination for metabolomics. , 2011, Journal of proteome research.
[83] J. Idle,et al. A comprehensive understanding of thioTEPA metabolism in the mouse using UPLC-ESI-QTOFMS-based metabolomics. , 2011, Biochemical pharmacology.
[84] J. Griffin,et al. Cryogenic probe 13C NMR spectroscopy of urine for metabonomic studies. , 2002, Analytical chemistry.
[85] A. Lane,et al. Stable isotope-resolved metabolomics (SIRM) in cancer research with clinical application to nonsmall cell lung cancer. , 2011, Omics : a journal of integrative biology.
[86] Ruth E Ley,et al. Obesity and the human microbiome , 2010, Current opinion in gastroenterology.
[87] Rachel Cavill,et al. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). , 2009, Journal of proteome research.